Covered recipient · General Payments record
RISHI D GAIHA
Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine
General Payments · PY2019–2024
$4,573.71
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $561.40 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $274.79 | 8 |
| ABBVIE INC. | $157.20 | 6 |
| Merck Sharp & Dohme Corporation | $49.50 | 2 |
| Nevro Corp. | $32.98 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $24.04 | 1 |
| Avanos Medical | $22.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $37.16 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125949 | CMS |
| Abbott Laboratories | $15.74 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125951 | CMS |
| Abbott Laboratories | $12.78 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125953 | CMS |
| Abbott Laboratories | $39.80 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125955 | CMS |
| Abbott Laboratories | $20.92 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125957 | CMS |
| Abbott Laboratories | $41.12 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125963 | CMS |
| Abbott Laboratories | $81.56 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125959 | CMS |
| Abbott Laboratories | $25.71 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125125961 | CMS |
| ABBVIE INC. | $32.77 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764530 | CMS |
| ABBVIE INC. | $24.81 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764532 | CMS |
| ABBVIE INC. | $31.23 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764534 | CMS |
| ABBVIE INC. | $29.76 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764536 | CMS |
| ABBVIE INC. | $29.75 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764538 | CMS |
| ABBVIE INC. | $8.88 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103764540 | CMS |
| Avanos Medical | $22.89 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149305699 | CMS |
| Merck Sharp & Dohme LLC | $24.75 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141810768 | CMS |
| Merck Sharp & Dohme LLC | $24.75 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141810764 | CMS |
| Nevro Corp. | $32.98 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130750632 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $24.04 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105914562 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.